Financial Architects (New Jersey)’s Standard BioTools LAB Stock Holding History

Financial Architects (New Jersey)’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-300	Closed	-$4K	–	1347
2019 Q1	$4K	Buy	+300	New	+$3.16K	﹤0.01%	1251
2015 Q3	–	Sell	-2,000	Closed	-$48K	–	590
2015 Q2	$48K	Sell	2,000 -2,000	-50%	-$63.1K	0.02%	446
2015 Q1	$168K	Hold	4,000	–	–	0.07%	215
2014 Q4	$135K	Hold	4,000	–	–	0.06%	214
2014 Q3	$98K	Hold	4,000	–	–	0.05%	225
2014 Q2	$118K	Buy	+4,000	New	+$128K	0.06%	200
2013 Q4	–	Sell	-4,000	Closed	-$88K	–	374
2013 Q3	$88K	Hold	4,000	–	–	0.06%	191
2013 Q2	$70K	Buy	+4,000	New	+$70.2K	0.05%	206

Other funds holding LAB

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Financial Architects (New Jersey)'s LAB Position: Q2 2019 in Review

Financial Architects (New Jersey) sold out of Standard BioTools (LAB) in Q2 2019, closing a stake of 300 shares — an estimated $4K sold.

Financial Architects (New Jersey) first reported a position in LAB in Q2 2013 and held it in 8 quarters. The position peaked at $168K in Q1 2015. 135 funds tracked by Wall St. Rank hold LAB as of Q2 2019.

Financial Architects (New Jersey) reported no remaining Standard BioTools position as of Q2 2019 after selling out during the quarter.
Financial Architects (New Jersey) sold 300 Standard BioTools shares in Q2 2019, an estimated $4K.
Financial Architects (New Jersey) first reported a position in Standard BioTools in Q2 2013 and held it in 8 quarters.
Financial Architects (New Jersey)'s Standard BioTools position peaked at $168K in Q1 2015.
135 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2019, filed 14 Aug 2019.